Clin2
NCT05732155Worth exploringRecruiting

MDMA-assisted therapy for Israeli veterans with PTSD

Post Traumatic Stress DisorderMoral InjuryMDMA ('Ecstasy')

Part of Mental health clinical trials.

This study tests whether MDMA (the active ingredient in Ecstasy) given in therapy sessions can help Israeli special forces veterans with PTSD and moral injury. Participants will receive MDMA alongside talk therapy to see if it reduces symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be a veteran of a special forces undercover unit in the Israeli army
  • Have moderate to severe PTSD symptoms for at least 6 months
  • Be fluent in Hebrew and able to swallow pills
  • Agree to have sessions recorded, stay overnight after MDMA sessions, and have a contact person reachable by the study team
  • Not have used MDMA more than 10 times in the last 10 years or in the last 6 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06394284Recruiting· Phase 3
MDMA therapy for PTSD in male Israeli veterans

This study tests whether MDMA (the drug in Ecstasy) can help male Israeli veterans with PTSD feel better, especially if their symptoms are related to moral injury. It involves therapy sessions and monitoring to see how the drug affects your brain and emotions.

Jerusalem
NCT05790239Recruiting· Phase 2
MDMA therapy sessions for veterans with PTSD

This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.

Los Angeles, California
NCT07569159Recruiting· Phase 2
MDMA-assisted therapy for veterans with PTSD

This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.

Rockville, Maryland
NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in military members

This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.

NCT07288151Recruiting· Phase 2
MDMA with Exposure Therapy for PTSD

This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.

Atlanta, Georgia
NCT05943665Recruiting· Phase 2
MDMA-assisted therapy for PTSD and alcohol use in veterans

This study tests whether MDMA, given in a controlled clinical setting, can reduce symptoms of PTSD and alcohol use disorder in veterans. It also combines the medication with structured therapy sessions to help you manage symptoms without relying on alcohol or other substances.

Providence, Rhode Island

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.